Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01335412 · ClinicalTrials.gov registry record
Safety Surveillance After Immunization With IXIARO
A clinical trial, sponsored by Valneva Austria.
- Completed
- Registry status
- 20,000
- Enrollment target
NCT01335412 is a clinical trial that has completed, run by Valneva Austria. The registered enrollment target is 20,000 participants.
The verdict
NCT01335412 has completed, sponsored by Valneva Austria.
- COMPLETED
- Registry status
- 20,000 participants
- Enrollment target
Study Summary
This is an active electronic surveillance using data from the Defense Medical Surveillance System (DMSS) to detect and characterize serious, rare adverse events occurring within 42 days after vaccination with the Japanese Encephalitis Vaccine IXIARO within the US Military, to detect adverse events that occur more frequently after IXIARO and to electronically follow up pregnancies during or shortly before which IXIARO was administered. There will be no intervention and no individuals contacted.
Interventions
- BIOLOGICAL Japanese Encephalitis Virus vaccine, inactivated, adsorbed
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,000 participants |
| Start Date | 2011-03 |
| Est. Completion | 2013-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01335412
The ClinicalTrials.gov registry entry for NCT01335412 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Valneva Austria, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Japanese Encephalitis Virus vaccine, inactivated, adsorbed is the first listed.
NCT01335412 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01335412 about?
NCT01335412 is a clinical study titled "Safety Surveillance After Immunization With IXIARO". This is an active electronic surveillance using data from the Defense Medical Surveillance System (DMSS) to detect and characterize serious, rare adverse events occurring within 42 days after vaccination with the Japanese Encephalitis Vaccine IXIARO within the US Military, to detect adverse events t...
What is the current status of trial NCT01335412?
This trial is currently completed. The enrollment target is 20,000 participants. The study started on 2011-03. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01335412?
The interventions under investigation include: Japanese Encephalitis Virus vaccine, inactivated, adsorbed (BIOLOGICAL).
Who is sponsoring clinical trial NCT01335412?
This trial is sponsored by Valneva Austria, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.